Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mitochondrial mutation m.1555A>G as a risk factor for failed newborn hearing screening in a large cohort of preterm infants.

BMC pediatrics - 26 Aug 2014

Göpel Wolfgang, Berkowski Sandra, Preuss Michael, Ziegler Andreas, Küster Helmut, Felderhoff-Müser Ursula, Gortner Ludwig, Mögel Michael, Härtel Christoph, Herting Egbert

Abstract excerpt

BACKGROUND: The mitochondrial m.1555A>G mutation is associated with a high rate of permanent hearing loss, if aminoglycosides are given. Preterm infants have an increased risk of permanent hearing loss and are frequently treated with aminoglycoside antibiotics. METHODS: We genotyped preterm infants with a birth weight below 1500 grams who were prospectively enrolled in a large cohort study for the m.1555A>G...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminoglycosides
Share to Anti-Bacterial Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Mitochondrial

Share to Hearing Loss

Share to Hearing Tests

Share to Infant, Premature

Share to Infant, Very Low Birth Weight

Share to Neonatal Screening

Source

Open in PubMed Open full text

Identifiers

PMID: 25155176
DOI: 10.1186/1471-2431-14-210
PMCID: PMC4236616

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mitochondrial mutation m.1555A>G as a risk factor for failed newborn hearing screening in a large cohort of preterm infants.PMID 25155176Read ↗

Gentamicin, genetic variation and deafness in preterm children.Semantic proximity Read ↗

Defining the cellular and molecular mechanism of maternally inherited hearing lossSemantic proximity Read ↗

The future role of genetic screening to detect newborns at risk of childhood-onset hearing loss.Semantic proximity Read ↗

Non-invasive Prenatal MT-RNR1 Pharmacogenetic Testing for the Prevention of Aminoglycoside-Induced Profound Hearing LossSemantic proximity Read ↗

Maternally inherited hearing impairment.Semantic proximity Read ↗

A cohort study of neonatal hearing testing and genetic screening for variants associated with susceptibility to aminoglycoside antibiotic-induced hearing loss in Beijing, China.Semantic proximity Read ↗

Detecting mitochondrial mutations associated with aminoglycoside ototoxicity by noninvasive prenatal testing.Semantic proximity Read ↗

The A1555G mitochondrial DNA mutation in Greek patients with non-syndromic, sensorineural hearing loss.Semantic proximity Read ↗

Screening of the mitochondrial A1555G mutation in patients with sensorineural hearing loss.Semantic proximity Read ↗

Hearing loss due to the mitochondrial A1555G mutation in Italian families.Semantic proximity Read ↗

Prevalence and clinical features of the mitochondrial m.1555A>G mutation in Taiwanese patients with idiopathic sensorineural hearing loss and association of haplogroup F with low penetrance in three families.Semantic proximity Read ↗

Sensorineural Hearing Loss in Patients With the m.1555A>G Mutation in the MTRNR1 Gene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.